| Net Cash Provided by (Used in) Operating Activities |
$160,039 |
USD |
82% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$90,000 |
USD |
-89% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$180,000 |
USD |
-395% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Shares, Issued |
3,445,000 |
shares |
0% |
Q2 2025 |
Q2 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$250,039 |
USD |
-246% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$563,038 |
USD |
55% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2025 |
Q2 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q2 2025 |
Q2 2025 |
| Additional Paid in Capital |
$613,937 |
USD |
|
Q2 2025 |
Q2 2025 |
| Interest Expense |
$236,170 |
USD |
44% |
Q2 2025 |
Q2 2025 |